Premier Biotech Acquires Desert Tox
June 6, 2024
Premier Biotech, a toxicology testing provider backed by Align Capital Partners, has acquired Desert Tox, LLC, a SAMHSA‑certified laboratory that provides urine and oral fluid testing across HHS/DOT, employment, occupational health and government markets. The founders, Mike Grommes and Mike Gorman, will remain involved; the deal is Premier's first add-on since ACP's acquisition in November 2022 and expands Premier's national service offering and oral fluids capabilities.
- Targets
- Desert Tox, LLC
- Sellers
- Mike Grommes, Mike Gorman
- Platforms
- Premier Biotech
- Industry
- Healthcare Services
- Location
- Arizona, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.